Part 2
Last week, we started a new series featuring healthcare visionary and thought leader Andy Dé. In this series, Dé discusses how COVID-19 has triggered remarkable digital transformation and uncovers five long-term innovation implications that providers, healthcare leaders, and payers need to consider.
Catch up on the first implication—advanced analytics for vaccine administration—then read on to explore number two in this week’s article.
Innovation implication #2: Digital patient engagement and virtual healthcare delivery
Protecting the health, well-being and safety of healthcare practitioners and first responders is paramount — and will accelerate adoption of Digital Patient Engagement (DPE), enabled by Virtual Healthcare Delivery (VHD) solutions (also known as “Hospital at Home.)”
As pictured below, there are three primary drivers for DPE and VHD:
- A clear need to deliver high quality healthcare to a massive number of patients afflicted with a contagious disease and co-morbidities.
- Risks presented by acquiring COVID-19 combined with continued lack of sufficient equipment, PPE, and rest for healthcare workers
- The need to minimize direct contact of providers with patients while increasing level of care efficiency and productivity

When I have this conversation with healthcare colleagues, the next question I typically receive is: “Andy, this sounds great, but where do we start?” The chart below demonstrates several helpful examples of how technology can be used to transform typical patient interactions and needs:

If you’re interested in more details about how to actually make changes like the ones described above, reach out to start a conversation. Join me back here on the MedeAnalytics blog next week for Innovation implications #3: Artificial intelligence and machine learning for operations, revenue cycle and supply change management innovation and #4: Medical robotics.
Get our take on industry trends
The GLP-1 Insights Series, Part 2: Maximizing impact and savings through analytics
GLP-1s present a major opportunity for organizations to improve clinical outcomes and reduce long-term healthcare costs. However, payers and providers…
Read on...The GLP-1 Insights Series, Part 1: Long-term impact on costs and outcomes for payers and providers
Few pharmaceuticals have surged in popularity as fast as GLP-1s. This growth is well-justified. GLP-1s, a class of medications originally…
Read on...Healthcare Data Interoperability: Why Is Healthcare Still Struggling to Share Data?
Key takeaways from The Sequoia Project’s 2025 Annual Meeting to speed up healthcare data interoperability I recently attended The…
Read on...Helping Accountable Care Organizations Navigate the Perfect Storm
In the ever-evolving landscape of healthcare, Accountable Care Organizations (ACOs) find themselves at the epicenter of a transformative era. Recently,…
Read on...